FDA Adverse Event Malfunction Summary report: N

HEMOCHRON SIGNATURE MICROCOAGULATION SYSTEM

MDR report key: 1665478 · Received April 16, 2010

Report

Report Number
2248721-2010-00027
Event Type
Malfunction
Date Received
April 16, 2010
Date of Event
February 3, 2010
Report Date
March 16, 2010
Manufacturer
INTERNATIONAL TECHNIDYNE CORP.
Product Code
JPA
PMA / PMN Number
K050016
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). MANUFACTURER AWAITING FURTHER INFORMATION TO EVALUATE PRODUCT COMPLAINT.

Description of Event or Problem · 1

HEALTHCARE PROVIDER REPORTS: SIGNATURE INSTRUMENT GAVE LOWER THAN EXPECTED ACT RESULTS THAT DID NOT MATCH THE STATUS OF THREE PATIENTS. AN (B)(6) POST SENNING PROCEDURE AND WAS ON ECMO. HEMOCHRON JR. ACT-LR RESULTS: 155, 130, 142, 132, 141, 140. THE RESULTS WERE REPORTED AS LOWER FOR "K" LOT CUVETTES COMPARED TO TWO OTHER CUVETTE LOTS. NO REPORT OF ADVERSE EVENT OR SERIOUS INJURY.

Additional Manufacturer Narrative · 2

(B)(4). MANUFACTURER AWAITING FURTHER INFORMATION TO EVALUATE PRODUCT COMPLAINT.

Description of Event or Problem · 2

HEALTHCARE PROVIDER REPORTS: SIGNATURE INSTRUMENT GAVE LOWER THAN EXPECTED ACT RESULTS THAT DID NOT MATCH THE STATUS OF THREE PATIENTS. A (B)(6) POST ECMO. HEMOCHRON JR. ACT-LR RESULTS WERE REPORTED AS LOWER FOR "K" LOT CUVETTES COMPARED TO TWO OTHER CUVETTE LOTS. NO REPORT OF ADVERSE EVENT OR SERIOUS INJURY.

Additional Manufacturer Narrative · 3

(B)(4). MANUFACTURER AWAITING FURTHER INFORMATION TO EVALUATE PRODUCT COMPLAINT.

Description of Event or Problem · 3

HEALTHCARE PROVIDER REPORTS: SIGNATURE INSTRUMENT GAVE LOWER THAN EXPECTED ACT RESULTS THAT DID NOT MATCH THE STATUS OF THREE PATIENTS. A (B)(6) POST ECMO. HEMOCHRON JR. ACT-LR RESULTS REPORTED AS LOWER FOR "K" LOT CUVETTES COMPARED TO TWO OTHER CUVETTE LOTS. NO REPORT OF ADVERSE EVENT OR SERIOUS INJURY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 HEMOCHRON SIGNATURE MICROCOAGULATION SYSTEM SIGNATURE INST JPA INTERNATIONAL TECHNIDYNE CORP. JACT+

Patients

Seq Age Sex Outcome Treatment
1 8 MO
2 4 YR
3 16 YR